EFDID: 70848EFD: Raw Data

Issuer: Reven Pharmaceuticals, Inc. (0001556231) - D/A

Accession: 0000897069-13-000270 () (EDGAREDGAR Files) (Form DForm D)

Edgar Posted: Jun. 5, 2013
EFD Posted: Aug. 7, 2014
- < edgarSubmission >
  < schemaVersion > X0706 </ schemaVersion >
  < submissionType > D/A </ submissionType >
  < testOrLive > LIVE </ testOrLive >
- < primaryIssuer >
  < cik > 0001556231 </ cik >
  < entityName > Reven Pharmaceuticals, Inc. </ entityName >
- < issuerAddress >
  < street1 > 4411 BEE RIDGE ROAD </ street1 >
  < street2 > SUITE 285 </ street2 >
  < city > SARASOTA </ city >
  < stateOrCountry > FL </ stateOrCountry >
  < stateOrCountryDescription > FLORIDA </ stateOrCountryDescription >
  < zipCode > 34233 </ zipCode >
  </ issuerAddress >
  < issuerPhoneNumber > 941-320-9271 </ issuerPhoneNumber >
  < jurisdictionOfInc > FLORIDA </ jurisdictionOfInc >
- < issuerPreviousNameList >
  < previousName > Advanced Diagnostics International of Florida, Inc. </ previousName >
  < previousName > Noventis, Inc. </ previousName >
  </ issuerPreviousNameList >
- < edgarPreviousNameList >
  < value > None </ value >
  </ edgarPreviousNameList >
  < entityType > Corporation </ entityType >
- < yearOfInc >
  < overFiveYears > true </ overFiveYears >
  </ yearOfInc >
  </ primaryIssuer >
- < relatedPersonsList >
- < relatedPersonInfo >
- < relatedPersonName >
  < firstName > Peter </ firstName >
  < middleName > B. </ middleName >
  < lastName > Lange </ lastName >
  </ relatedPersonName >
- < relatedPersonAddress >
  < street1 > 4411 Bee Ridge Road </ street1 >
  < street2 > Suite 285 </ street2 >
  < city > Sarasota </ city >
  < stateOrCountry > FL </ stateOrCountry >
  < stateOrCountryDescription > FLORIDA </ stateOrCountryDescription >
  < zipCode > 34233 </ zipCode >
  </ relatedPersonAddress >
- < relatedPersonRelationshipList >
  < relationship > Executive Officer </ relationship >
  < relationship > Director </ relationship >
  </ relatedPersonRelationshipList >
  < relationshipClarification />
  </ relatedPersonInfo >
- < relatedPersonInfo >
- < relatedPersonName >
  < firstName > Brian </ firstName >
  < lastName > Denomme </ lastName >
  </ relatedPersonName >
- < relatedPersonAddress >
  < street1 > 4411 Bee Ridge Road </ street1 >
  < street2 > Suite 285 </ street2 >
  < city > Sarasota </ city >
  < stateOrCountry > FL </ stateOrCountry >
  < stateOrCountryDescription > FLORIDA </ stateOrCountryDescription >
  < zipCode > 34233 </ zipCode >
  </ relatedPersonAddress >
- < relatedPersonRelationshipList >
  < relationship > Executive Officer </ relationship >
  < relationship > Director </ relationship >
  </ relatedPersonRelationshipList >
  < relationshipClarification />
  </ relatedPersonInfo >
- < relatedPersonInfo >
- < relatedPersonName >
  < firstName > Michael </ firstName >
  < lastName > Handley </ lastName >
  </ relatedPersonName >
- < relatedPersonAddress >
  < street1 > 4411 Bee Ridge Road </ street1 >
  < street2 > Suite 285 </ street2 >
  < city > Sarasota </ city >
  < stateOrCountry > FL </ stateOrCountry >
  < stateOrCountryDescription > FLORIDA </ stateOrCountryDescription >
  < zipCode > 34233 </ zipCode >
  </ relatedPersonAddress >
- < relatedPersonRelationshipList >
  < relationship > Executive Officer </ relationship >
  </ relatedPersonRelationshipList >
  < relationshipClarification />
  </ relatedPersonInfo >
  </ relatedPersonsList >
- < offeringData >
- < industryGroup >
  < industryGroupType > Pharmaceuticals </ industryGroupType >
  </ industryGroup >
- < issuerSize >
  < revenueRange > Decline to Disclose </ revenueRange >
  </ issuerSize >
- < federalExemptionsExclusions >
  < item > 06 </ item >
  </ federalExemptionsExclusions >
- < typeOfFiling >
- < newOrAmendment >
  < isAmendment > true </ isAmendment >
  < previousAccessionNumber > 0000897069-13-000189 </ previousAccessionNumber >
  </ newOrAmendment >
- < dateOfFirstSale >
  < value > 2013-02-05 </ value >
  </ dateOfFirstSale >
  </ typeOfFiling >
- < durationOfOffering >
  < moreThanOneYear > false </ moreThanOneYear >
  </ durationOfOffering >
- < typesOfSecuritiesOffered >
  < isDebtType > true </ isDebtType >
  < isSecurityToBeAcquiredType > true </ isSecurityToBeAcquiredType >
  </ typesOfSecuritiesOffered >
- < businessCombinationTransaction >
  < isBusinessCombinationTransaction > false </ isBusinessCombinationTransaction >
  < clarificationOfResponse />
  </ businessCombinationTransaction >
  < minimumInvestmentAccepted > 5000 </ minimumInvestmentAccepted >
- < salesCompensationList >
- < recipient >
  < recipientName > Futures Investment Company </ recipientName >
  < recipientCRDNumber > 42402 </ recipientCRDNumber >
  < associatedBDName > None </ associatedBDName >
  < associatedBDCRDNumber > None </ associatedBDCRDNumber >
- < recipientAddress >
  < street1 > 5914 North 300 West </ street1 >
  < city > Fremont </ city >
  < stateOrCountry > IN </ stateOrCountry >
  < stateOrCountryDescription > INDIANA </ stateOrCountryDescription >
  < zipCode > 46737 </ zipCode >
  </ recipientAddress >
- < statesOfSolicitationList >
  < state > SD </ state >
  < description > SOUTH DAKOTA </ description >
  < state > SC </ state >
  < description > SOUTH CAROLINA </ description >
  < state > UT </ state >
  < description > UTAH </ description >
  < state > IL </ state >
  < description > ILLINOIS </ description >
  < state > NY </ state >
  < description > NEW YORK </ description >
  < state > IN </ state >
  < description > INDIANA </ description >
  < state > GA </ state >
  < description > GEORGIA </ description >
  < state > WI </ state >
  < description > WISCONSIN </ description >
  < state > AZ </ state >
  < description > ARIZONA </ description >
  < state > KY </ state >
  < description > KENTUCKY </ description >
  < state > CA </ state >
  < description > CALIFORNIA </ description >
  < state > MT </ state >
  < description > MONTANA </ description >
  < state > LA </ state >
  < description > LOUISIANA </ description >
  < state > VA </ state >
  < description > VIRGINIA </ description >
  < state > MI </ state >
  < description > MICHIGAN </ description >
  < state > OH </ state >
  < description > OHIO </ description >
  < state > WY </ state >
  < description > WYOMING </ description >
  < state > TX </ state >
  < description > TEXAS </ description >
  < state > CO </ state >
  < description > COLORADO </ description >
  < state > FL </ state >
  < description > FLORIDA </ description >
  < state > IA </ state >
  < description > IOWA </ description >
  < state > NC </ state >
  < description > NORTH CAROLINA </ description >
  < state > NE </ state >
  < description > NEBRASKA </ description >
  </ statesOfSolicitationList >
  < foreignSolicitation > true </ foreignSolicitation >
  </ recipient >
  </ salesCompensationList >
- < offeringSalesAmounts >
  < totalOfferingAmount > 2000000 </ totalOfferingAmount >
  < totalAmountSold > 526025 </ totalAmountSold >
  < totalRemaining > 1473975 </ totalRemaining >
  < clarificationOfResponse > May increase the offering to $4,000,000 of Notes. </ clarificationOfResponse >
  </ offeringSalesAmounts >
- < investors >
  < hasNonAccreditedInvestors > false </ hasNonAccreditedInvestors >
  < totalNumberAlreadyInvested > 16 </ totalNumberAlreadyInvested >
  </ investors >
- < salesCommissionsFindersFees >
- < salesCommissions >
  < dollarAmount > 0 </ dollarAmount >
  </ salesCommissions >
- < findersFees >
  < dollarAmount > 0 </ dollarAmount >
  </ findersFees >
  < clarificationOfResponse > The Selling Agent will be compensated solely in Shares equal to 4% of the first $500,000, 3% of the next $500,000 up to $1,000,000, and 2% of the final $1,000,000 sold in the Offering at ten cents ($0.10) per Share. </ clarificationOfResponse >
  </ salesCommissionsFindersFees >
- < useOfProceeds >
- < grossProceedsUsed >
  < dollarAmount > 54000 </ dollarAmount >
  < isEstimate > true </ isEstimate >
  </ grossProceedsUsed >
  < clarificationOfResponse />
  </ useOfProceeds >
- < signatureBlock >
  < authorizedRepresentative > false </ authorizedRepresentative >
- < signature >
  < issuerName > Reven Pharmaceuticals, Inc. </ issuerName >
  < signatureName > Peter B. Lange </ signatureName >
  < nameOfSigner > Peter B. Lange </ nameOfSigner >
  < signatureTitle > President </ signatureTitle >
  < signatureDate > 2013-06-05 </ signatureDate >
  </ signature >
  </ signatureBlock >
  </ offeringData >
  </ edgarSubmission >
Edgar Posted: Jun. 5, 2013
EFD Posted: Aug. 7, 2014